Jennifer Green

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Novo Nordisk Inc.(MODEST), Bayer(SIGNIFICANT), Hawthorne Effect/Omada(SIGNIFICANT), Pfizer(MODEST), Sanofi/Lexicon(MODEST), Vertex Pharmaceuticals(MODEST), Anji(MODEST) RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Roche(SIGNIFICANT)

View Full Disclosure